SCHEMBL6501299

SCHEMBL6501299

CC1(C)CCCC(C)(C)N1Oc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.34
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
CYP2B6 P20813 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
PRCP P42785 1/20 0.32
SLC6A3 Q01959 1/20 0.32
GRIN1 Q05586 1/20 0.32
KCNH2 Q12809 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
LTA4H P09960 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL27455943 0.91 TDP1 (0.35) KDM4ESIGMAR1TSHROPRM1
SCHEMBL6498977 0.82 ELANE (0.49) HSD17B10KDM4ELTA4HTSHR
SCHEMBL6503405 0.80 CYP1A2 (0.44) KDM4ESLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL6491935 0.79 CHRNB2 (0.41)
SCHEMBL6490088 0.77 PSMB1 (0.42) MAPK1KDM4ESLC6A2SLC6A3LTA4H
SCHEMBL4558226 0.76 GRIN1 (0.37) KDM4EGRIN2DGRIN3BCYP2B6SLC6A2
SCHEMBL2356015 0.76 TDP1 (0.39) MAPK1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL7028932 0.76 TSHR (0.39) TSHR
SCHEMBL8605624 0.74 TP53 (0.42) MAPK1HSD17B10KDM4ETSHR
SCHEMBL17350892 0.74 TSHR (0.41) CA4MAPK1HSD17B10SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579328-B2 Preparation from a sterically hindered nitroxy compound and a diazonium salt of an aromatic amine in the presence of a transition metal catalyst CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US claimed
US-20020007585-A1 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted aryloxyamines CIBA SPECIALTY CHEMICALS CORP. 2002-01-24 US claimed
JP-57061032-A None JP disclosed
JP-57061031-A None JP disclosed
JP-59109527-A None JP disclosed
US-6841668-B2 Polyoxometalate catalysts for the preparation of sterically hindered N-substituted aryloxyamines CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-01-11 US disclosed
US-20030208071-A1 Polyoxometalate catalysts for the preparation of sterically hindered N-substituted aryloxyamines CIBA SPECIALTY CHEMICALS CORP. 2003-11-06 US disclosed
US-6579328-B2 Preparation from a sterically hindered nitroxy compound and a diazonium salt of an aromatic amine in the presence of a transition metal catalyst CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
EP-1278733-A1 PROCESS FOR THE PREPARATION OF STERICALLY HINDERED ARYLOXYAMINES Ciba SC Holding AG (CH) 2003-01-29 EP disclosed
US-20020007585-A1 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted aryloxyamines CIBA SPECIALTY CHEMICALS CORP. 2002-01-24 US disclosed
WO-2001083455-A1 PROCESS FOR THE PREPARATION OF STERICALLY HINDERED ARYLOXYAMINES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-11-08 WO disclosed
JP-S59109527-A COATED POLYCARBONATE RESIN MOLDING SUMITOMO CHEM CO LTD 1984-06-25 JP disclosed
JP-S5761031-A POLYOLEFIN COMPOSITION MITSUBISHI CHEM IND LTD 1982-04-13 JP disclosed
JP-S5761032-A POLYOLEFIN COMPOSITION MITSUBISHI CHEM IND LTD 1982-04-13 JP disclosed
US-4211852-A PROPYLENE-BUTYLENE COPOLYMER MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1980-07-08 US disclosed
US-4186240-A Thermoplastic olefin resin composition and laminated film or sheet thereof MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1980-01-29 US disclosed
US-3948854-A Salicylic acid hydrazide stabilizers for polymers CIBA-GEIGY CORPORATION (US) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030208071-A1 Polyoxometalate catalysts for the preparation of sterically hindered N-substituted aryloxyamines KMO, PPOX, TAOK1 CA4 4606/4885MAPK1 222/4885HSD17B10 4157/4885
US-20020007585-A1 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted aryloxyamines SOD1, NNMT, TYR CA4 2239/4885MAPK1 2327/4885HSD17B10 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.